GENE ONLINE|News &
Opinion
Blog

2020-09-27| SpecialTechnology

Combining the Power of miRNAs and Nanotechnology to Prevent Osteoarthritis Progression

by GeneOnline
Share To
miRNAs belong to the category of non-coding RNAs. They block the expression of a gene either by binding to its specific mRNA and degrading it or by preventing the translation of the specific mRNA. More than 1900 miRNAs have been discovered to date in humans, and many of them have been implicated in various human diseases. Changes in the expression of miRNA have been involved in diseases like cancer, obesity, cardiovascular diseases, and osteoarthritis (OA).
Several miRNAs have been identified that are differentially expressed in OA . One of the first miRNA that has been linked to OA pathology is miRNA-140.

GO Prime with only $1.49 now

LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top